Peripheral Sensory Neurons in Chemotherapy-Induced Neuropathy
Overview
Peripheral sensory neurons are the primary cellular targets in chemotherapy-induced peripheral neuropathy (CIPN), a dose-limiting side effect affecting up to 70% of cancer patients receiving neurotoxic chemotherapeutic agents. These neurons, which comprise the sensory component of the peripheral nervous system (PNS), transmit pain, temperature, and tactile information from tissues throughout the body to the central nervous system. CIPN represents a specific form of iatrogenic neurodegeneration where chemotherapy agents, while targeting rapidly dividing cancer cells, inadvertently damage the sensory nerve fibers and their parent dorsal root ganglion (DRG) neurons. The condition is characterized by length-dependent axonal degeneration, primarily affecting distal lower extremities, manifesting as paresthesias, numbness, and neuropathic pain that can persist months to years after treatment completion.
Function/Biology
...Peripheral Sensory Neurons in Chemotherapy-Induced Neuropathy
Overview
Peripheral sensory neurons are the primary cellular targets in chemotherapy-induced peripheral neuropathy (CIPN), a dose-limiting side effect affecting up to 70% of cancer patients receiving neurotoxic chemotherapeutic agents. These neurons, which comprise the sensory component of the peripheral nervous system (PNS), transmit pain, temperature, and tactile information from tissues throughout the body to the central nervous system. CIPN represents a specific form of iatrogenic neurodegeneration where chemotherapy agents, while targeting rapidly dividing cancer cells, inadvertently damage the sensory nerve fibers and their parent dorsal root ganglion (DRG) neurons. The condition is characterized by length-dependent axonal degeneration, primarily affecting distal lower extremities, manifesting as paresthesias, numbness, and neuropathic pain that can persist months to years after treatment completion.
Function/Biology
Peripheral sensory neurons consist of two major functional classes: large-diameter myelinated neurons (Aα and Aβ fibers) that convey mechanical sensation and proprioception, and small-diameter unmyelinated neurons (C fibers) and lightly myelinated neurons (Aδ fibers) that transmit pain and temperature signals. The sensory neuron soma resides in the dorsal root ganglia, with a single axon bifurcating into a peripheral branch extending to skin, muscle, and visceral organs and a central branch synapsing within the dorsal spinal cord. Sensory neurons maintain extensive cytoplasmic compartments requiring constant axonal transport of proteins, lipids, and organelles. This metabolic demand makes them particularly vulnerable to mitochondrial dysfunction and impaired cargo trafficking. Ion channels (particularly voltage-gated sodium and calcium channels), growth factor receptors (TrkA, p75NTR), and neuropeptides (substance P, CGRP) are essential for signal transduction and axonal homeostasis. The axon comprises approximately 99% of neuronal volume, yet the soma must synthesize and transport all necessary proteins across distances exceeding one meter in lower extremity neurons.
Role in Neurodegeneration
In CIPN, sensory neurons undergo progressive axonal degeneration through a mechanism termed "dying-back" neuropathy, where the distal axon degenerates first, with pathology subsequently advancing proximally toward the soma. This length-dependent pattern correlates with the highest metabolic demand occurring in the most distal nerve terminals. Chemotherapy agents such as taxanes (paclitaxel, docetaxel), platinum compounds (cisplatin, oxaliplatin), and proteasome inhibitors (bortezomib) directly impair sensory neuron function through distinct mechanisms. Long-term survivors develop chronic sensory deficits and neuropathic pain, indicating incomplete neuronal recovery despite cessation of chemotherapy exposure. The sustained nature of CIPN suggests cumulative damage to sensory neuron organelles, particularly mitochondria, leading to chronic energy deficit and compromised axonal maintenance mechanisms.
Molecular Mechanisms
Chemotherapy-induced sensory neuron degeneration involves multiple converging pathways. Taxane chemotherapy stabilizes microtubules by promoting their polymerization, disrupting the dynamic reorganization of the neuronal cytoskeleton essential for axonal transport. This impairs kinesin and dynein motor protein-mediated transport of mitochondria, lysosomes, and signaling proteins along the axon. Platinum agents generate reactive oxygen species (ROS) within mitochondria, overwhelming antioxidant defenses and triggering mitochondrial outer membrane permeabilization, releasing cytochrome c and activating pro-apoptotic cascades. Proteasome inhibitors disrupt the ubiquitin-proteasome system, causing accumulation of misfolded proteins and triggering unfolded protein response (UPR) pathways, including activation of ATF4, XBP1, and caspase-12-mediated apoptosis. Calcium dysregulation through enhanced TRPV1 and TRPA1 channel activation contributes to excitotoxicity and mitochondrial calcium overload. Additionally, chemotherapy impairs mitochondrial calcium handling through suppressed expression of mitochondrial calcium uniporter (MCU) and altered VDAC1 function.
Clinical/Research Significance
CIPN represents a major clinical challenge lacking effective preventive or treatment strategies, driving intensive research into neuroprotective interventions. Understanding the cellular vulnerability of sensory neurons guides development of agents targeting oxidative stress, mitochondrial dysfunction, and protein aggregation. Biomarkers reflecting sensory neuron degeneration, including intraepidermal nerve fiber density measurement and assessment of small fiber function, enable early detection of CIPN before symptomatic manifestation. Preclinical studies employing primary DRG neuron cultures and transgenic mouse models expressing fluorescent axonal markers provide mechanistic insights into chemotherapy-induced damage pathways.
- Dorsal Root Ganglion (DRG) neurons
- Mitochondrial dysfunction and oxidative stress
- Axonal transport impairment
- Neuroinflammation and microglial activation
- Neuropathic pain signaling (TRPV